CP and COVID-19: To that end, even though treatment with CP may not affect mortality in these patients, the possibility for faster elimination of the virus, reduction in the possibility of future admissions for COVID-19 and the possibility for reduction in the severity of remaining symptoms, even though this was not directly assessed in the present study, could justify the use of CP in this patient population.